North America: Food, Drugs, Healthcare, Life Sciences

On May 6, 2026, the U.S. Food and Drug Administration (FDA) announced the launch of its “One-Day Inspectional Assessment” pilot program, an initiative designed to conduct shorter, more targeted inspections at certain FDA-regulated facilities across all FDA product areas, including food, drugs, biologics, and medical products.

The healthcare sector is being impacted by a number of key factors, including increased integration of artificial intelligence, a focus on chronic disease management and the drive for administrative efficiency.

Public attention surrounding hantavirus outbreaks often focuses, understandably, on the immediate health risks associated with rodent exposure. Recent reports tied to a cruise vessel outbreak of hantavirus...